Evidence map›Paper›PMID 42147088›Full record

ArticleChemistry of materials : a publication of the American Chemical Society2026

Facile Synthesis of Rhodium Nanodendrites with Enhanced Activity toward Hydrazine-Assisted Water Splitting.

Jiaqi Guan, Zhiqi Wang, Kei Kwan Li, Yong Ding, Younan Xia

Abstract read
In one paragraph

Article in Chemistry of materials : a publication of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiaqi GuanSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Zhiqi WangSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Kei Kwan LiSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Yong DingSchool of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Younan XiaSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.ORCID https://orcid.org/0000-0003-2431-7048

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report an aqueous synthesis of Rhodium (Rh) nanodendrites and evaluation of their merit as a bifunctional electrocatalyst toward hydrazine-assisted water splitting. The formation of dendritic morphology can be attributed to the fast reduction kinetics responsible for burst nucleation and then attachment growth. Rapid reduction results in a high concentration of Rh atoms, which quickly nucleate and grow into ultrafine Rh nanocrystals, followed by their evolution into dendritic structures through attachment growth. Extending the reaction time naturally prolongs the number of branched arms while increasing the overall size of the particles. Aging the Rh-(III) precursor solution slows down the reduction kinetics, leading to the formation of fewer Rh nanoparticles for the generation of smaller dendrites. The reaction temperature influences the reduction kinetics during nucleation and then aggregation thermodynamics governing the attachment process. Together with a high specific surface area, the lattice defects arising from attachment growth induce tensile strain, resulting in more and better catalytic sites. When evaluated as a bifunctional electrocatalyst toward hydrazine oxidation and hydrogen evolution reactions, the Rh nanodendrites gave an enhanced mass activity of 162.0 A mg

Identifiers

PMID42147088
PMCPMC13173500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.